Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral Versus Intravenous Antibiotic Treatment for Febrile Neutropenia in Cancer Patients." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451517/all/_________Oral_versus_intravenous_antibiotic_treatment_for_febrile_neutropenia_in_cancer_patients______.
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/451517/all/_________Oral_versus_intravenous_antibiotic_treatment_for_febrile_neutropenia_in_cancer_patients______. Accessed April 22, 2025.
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/451517/all/_________Oral_versus_intravenous_antibiotic_treatment_for_febrile_neutropenia_in_cancer_patients______
Oral Versus Intravenous Antibiotic Treatment for Febrile Neutropenia in Cancer Patients [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451517/all/_________Oral_versus_intravenous_antibiotic_treatment_for_febrile_neutropenia_in_cancer_patients______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
ID - 451517
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451517/all/_________Oral_versus_intravenous_antibiotic_treatment_for_febrile_neutropenia_in_cancer_patients______
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -